Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Skin Therapy Letter|September 19, 2015
Apremilast in the treatment of psoriasis and psoriatic arthritisM Gooderham, K PappSkin Therapy Letter|May 26, 2016
Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current LiteratureK Blakely, M Gooderham, K PappSkin Therapy Letter|March 22, 2018
Brodalumab: A Review of SafetyS Rusta-Sallehy, M Gooderham, K PappThe British Journal of Dermatology|July 2, 2014
Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of ageM Gooderham, J-M Debarre, J Keddy-Grant, et al.The British Journal of Dermatology|June 18, 2014
A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoinJ Tan, S Humphrey, R Vender, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2017
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3C L Leonardi, A Blauvelt, H L Sofen, et al.The British Journal of Dermatology|September 13, 2018
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti-GM-CSF monoclonal antibodyK A Papp, M Gooderham, R Jenkins, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 15, 2020
Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trialsL Puig, T-F Tsai, T Bhutani, et al.Pageof 3